| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Jan 2026 | 20 Jan 2026 |
| Quarterly Results Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. | ||
| Board Meeting | 14 Oct 2025 | 6 Oct 2025 |
| Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2025 inter alia to consider and approve a. Consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025. b. Declaration of an Interim Dividend on the equity shares of the Company for the Financial Year 2025-26; and c. Proposal for issue of bonus shares in accordance with the applicable provisions of the Companies Act 2013 (including the rules framed thereunder) and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 and subject to requisite approval. Outcome of the Board Meeting held on October 14, 2025, for the approval of financial results for the quarter and half year ended September 30, 2025, interim dividend, issuance of bonus shares, and other matters as detailed in the enclosed letter. (As per BSE Announcement dated on: 14.10.2025) | ||
| Board Meeting | 23 Jul 2025 | 16 Jul 2025 |
| Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 inter alia to consider and approve unaudited financial results for quarter ended June 30 2025. Please find attached the disclosures regarding the appointment of Mr. Alok Kumar Jagnani as an Additional Director (Non-Executive & Non-Independent) and the noting of resignation of Mr. Hardik Dedhia from the Directorship of the Company. (As Per BSE Announcement Dated on: 23.07.2025) | ||
| Board Meeting | 23 Apr 2025 | 15 Apr 2025 |
| Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and to recommend the final dividend, if any, for the financial year 2024-25. Outcome of Board Meeting held on April 23, 2025 Please find attached herewith Intimation herewith for the appointment of Secretarial Auditors and re-appointment of Cost Auditor. (As per BSE Announcement Dated on 23/04/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
